Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022129 |
---|---|
Receipt number | R000025489 |
Scientific Title | The clinical trials for safety and usefulness of chronic hepatitis therapeutics,agent 3-oxygelmillpropionic acid polymer for the advanced and recurrent colorectal cancer of having the existing chemotherapeutic refractory or intolerance.(Phase 1 test) |
Date of disclosure of the study information | 2016/04/28 |
Last modified on | 2021/11/04 15:51:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/04/28 22:26:03 | ||
2 | Update | 2016/07/06 16:40:16 | UMIN ID1 |
|
3 | Update | 2016/07/12 21:25:41 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
4 | Update | 2016/07/12 21:27:15 | Date of protocol fixation Anticipated trial start date |
|
5 | Update | 2021/05/25 15:58:53 | UMIN ID2 |
|
6 | Update | 2021/11/04 11:11:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Organization Organization Address Address Tel |
|
7 | Update | 2021/11/04 15:51:42 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |